Your browser doesn't support javascript.
loading
Wuhan to World: The COVID-19 Pandemic.
Kumar, Ashok; Singh, Rita; Kaur, Jaskaran; Pandey, Sweta; Sharma, Vinita; Thakur, Lovnish; Sati, Sangeeta; Mani, Shailendra; Asthana, Shailendra; Sharma, Tarun Kumar; Chaudhuri, Susmita; Bhattacharyya, Sankar; Kumar, Niraj.
Afiliação
  • Kumar A; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Singh R; Manipal Academy of Higher Education, Manipal, India.
  • Kaur J; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Pandey S; Jawaharlal Nehru University, New Delhi, India.
  • Sharma V; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Thakur L; Jawaharlal Nehru University, New Delhi, India.
  • Sati S; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Mani S; Jawaharlal Nehru University, New Delhi, India.
  • Asthana S; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Sharma TK; Central University of Haryana, Mahendragarh, India.
  • Chaudhuri S; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
  • Bhattacharyya S; Jawaharlal Nehru University, New Delhi, India.
  • Kumar N; Translational Health Science and Technology Institute (THSTI), Faridabad, India.
Front Cell Infect Microbiol ; 11: 596201, 2021.
Article em En | MEDLINE | ID: mdl-33859951
ABSTRACT
COVID-19 is a Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV-2, a novel virus which belongs to the family Coronaviridae. It was first reported in December 2019 in the Wuhan city of China and soon after, the virus and hence the disease got spread to the entire world. As of February 26, 2021, SARS-CoV-2 has infected ~112.20 million people and caused ~2.49 million deaths across the globe. Although the case fatality rate among SARS-CoV-2 patient is lower (~2.15%) than its earlier relatives, SARS-CoV (~9.5%) and MERS-CoV (~34.4%), the SARS-CoV-2 has been observed to be more infectious and caused higher morbidity and mortality worldwide. As of now, only the knowledge regarding potential transmission routes and the rapidly developed diagnostics has been guiding the world for managing the disease indicating an immediate need for a detailed understanding of the pathogen and the disease-biology. Over a very short period of time, researchers have generated a lot of information in unprecedented ways in the key areas, including viral entry into the host, dominant mutation, potential transmission routes, diagnostic targets and their detection assays, potential therapeutic targets and drug molecules for inhibiting viral entry and/or its replication in the host including cross-neutralizing antibodies and vaccine candidates that could help us to combat the ongoing COVID-19 pandemic. In the current review, we have summarized the available knowledge about the pathogen and the disease, COVID-19. We believe that this readily available knowledge base would serve as a valuable resource to the scientific and clinical community and may help in faster development of the solution to combat the disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Global / Pandemias / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Saúde Global / Pandemias / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia